INTENSIVE COURSE IN HIV & AGING

CME/CE credit available October 1, 2020 – August 15, 2021.

Estimated time to complete all chapters: 10 hours

This activity is supported by an independent educational grant from Merck Pharmaceuticals.

Target Audience

This activity is intended for physicians, physician assistants, nurse practitioners, nurses and pharmacists and other healthcare providers who treat, diagnose and refer older patients with HIV disease or work in the field of gerontology.

Educational Objectives

After participating in this activity, the participant should be better able to:

  • Incorporate into clinical practice, novel strategies for long-term management of HIV disease in older patients, including when to start ART and preferred regimens for this population
  • Utilize best practice strategies to care for and treat common co-morbid conditions of older age in HIV, such as CVD, cancers, depression, diabetes mellitus, and metabolic syndrome;
  • Articulate an appropriate treatment plan for an older patient with HIV addressing a co-morbid condition common to aging with HIV.

Faculty

Aroonsiri Howell, MD, MPH; Assistant Professor of Internal Medicine; Lewis Katz School of Medicine, Temple University

Jonathan Appelbaum, MD, FACP, AAHIVS; Professor of Internal Medicine; Florida State University College of Medicine

Noelle Marie Javier, MD; Associate Professor of Internal Medicine, Geriatrics and Palliative Medicine; Ichan School of Medicine at Mount Sinai

 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the American Academy of HIV Medicine.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

October 7, 2020-December 2, 2020 Courses

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 10.0 contact hour(s) (1.0CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number – JA4008162-9999-20-2300-L02-PType of Activity: Application

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 10.0 contact hours.

Course 2-December 30, 2020-February 24, 2021

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 10.0 contact hour(s) (1.0CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number – JA4008162-9999-21-2301-H02-P

Type of Activity: Application

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 10.0 contact hours.

Course 3-March 24, 2021-May 12, 2021

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 10.0 contact hour(s) (1.0CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number – JA4008162-9999-21-2302-H02-P

Type of Activity: Application

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 10.0 contact hours.

Course 4-June 9, 2021-August 4, 2021

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 10.0 contact hour(s) (1.0CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number – JA4008162-9999-21-2303-H02-P

Type of Activity: Application

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 10.0 contact hours.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Faculty Name and Degree(s)

Dr. Aroonsiri Howell. MD, MPH has nothing to disclose.

Dr. Noelle Marie Javier, MD has nothing to disclose.

Faculty Name and Degree(s)

Dr. Jonathan Appelbaum, MD, FACP, AAHIVS

Consulting fees from Merck Pharmaceuticals, ViiV Healthcare

Planners and Managers

The PIM planners and managers have nothing to disclose. The Academy of HIV Medicine planners and managers have nothing to disclose

Method of Participation and Request for Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period October 7, 2020 through August 4, 2021, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 15755. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.

Media

Internet

Computer System Requirements

Participants will need access to Google Classroom to participate in this activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.